Visa Inc (V) Stock News

Pershing Square (PS) stock has fallen 25% from its October peak of $60 to $45 after Citi and Bank of America downgraded it to sell/underperform, citing overvaluation at 54x forward earnings. Both analysts lowered earnings projections due to tepid investment performance and modest expected returns, despite the stock's 87% surge since its April IPO.

The article argues that the Vanguard S&P 500 ETF (VOO) is a solid long-term investment due to its built-in momentum strategy through index constituent changes, resilience against inflation through corporate earnings growth, and historical data showing the S&P 500 has never had negative returns over rolling 20-year periods since 1936.

Apple has reached a $5 trillion market valuation under new CEO John Ternus, following Tim Cook's 15-year tenure that saw the company's stock gain over 2,600%. Despite the high valuation, Apple continues to outperform the S&P 500 by double the year-to-date growth rate (27% vs 13%), driven by strong iPhone sales and its interconnected ecosystem of products. The company's measured approach to AI integration and focus on consumer hardware are attracting investor interest, though the stock's P/E ratio of 39 suggests it may be expensive for new buyers.

Despite declining Eylea sales, Regeneron's strong performance is driven by Dupixent, a blockbuster drug developed with Sanofi that generated $6 billion in global sales with 38% year-over-year growth. The company's Q2 revenue grew 17% to $4.3 billion, with Dupixent collaboration revenue jumping 51%. While Dupixent faces biosimilar competition in the early 2030s, Regeneron plans to defend its market position through improved formulations, pipeline replacements, and promising candidates like olatorepatide in the weight-loss market.

Vistra stock surged 11% following a $4.2 billion conditional DOE loan commitment to modernize three nuclear power plants, adding 433 megawatts of capacity. While the company shows strong fundamentals with 30% EBITDA growth and analyst Strong Buy ratings, investors should note the loan requires meeting technical and financial requirements, and execution risks remain around project delays and cost overruns.

Rivian's most valuable opportunity may lie in its robotics venture rather than vehicle sales. The company owns approximately one-third of Mind Robotics, an AI-enabled manufacturing technology company founded by Rivian CEO RJ Scaringe. Mind recently hired Doug Field, a veteran executive from Tesla and Ford, as president. With a stake valued at over $1 billion and $1 billion in recent funding, Mind Robotics could provide significant returns for Rivian investors if successful, though Rivian's EV business still needs to achieve profitability.

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Dun & Bradstreet Holdings, alleging false and misleading statements regarding a merger with Clearlake Capital Group, including omissions about executive interests and financial advisor conflicts. Additional cases involve Duolingo, Inc. and XTI Aerospace, Inc. The lead plaintiff deadline for the DNB case is November 10, 2026.

Rosen Law Firm is urging Duolingo investors who purchased stock between May 2, 2025 and February 26, 2026 to join a securities class action lawsuit. The lawsuit alleges that Duolingo made false statements about user growth by concealing that increased monetization efforts, ad volume, and lower-quality AI-generated content were negatively impacting daily active users and product quality. The lead plaintiff deadline is December 7, 2026.

A securities fraud class action lawsuit has been filed against AEVEX Corp. (NYSE: AVEX) for allegedly making material misstatements regarding a pre-arranged secondary public offering shortly after its April 2026 IPO. The company failed to disclose that Madison Dearborn Partners planned to waive lock-up restrictions and sell shares, causing the stock to plummet approximately 23% in early June 2026. Investors have until October 20, 2026, to file for lead plaintiff status.

Kratos Defense is betting on military demand for its autonomous Valkyrie aircraft, which has demonstrated its technology. However, the key question for investors is whether the company can convert this validation into sufficient funded production orders to justify its expanding capacity.

While the stock market faces vulnerabilities from persistent inflation, AI investment risks, and high valuations, investors shouldn't panic sell. Instead, they should evaluate whether their holdings can withstand downturns, diversify portfolios, maintain financial flexibility, and distinguish between fundamentally weak businesses and temporarily depressed quality companies that could present buying opportunities.

A class action lawsuit has been filed against AEVEX Corp. alleging that the company and underwriters concealed a pre-arranged plan to prematurely override a 180-day lock-up agreement following its April 2026 IPO. The alleged scheme would have allowed Madison (the majority shareholder) to conduct a secondary public offering worth over $200 million shortly after the IPO. Investors who purchased shares during the IPO or between April 17 and June 4, 2026 have until October 20, 2026 to apply as lead plaintiff.

A securities class action lawsuit has been filed against Better Home & Finance Holding Company (BETR) for allegedly making false and misleading statements about its conversion funnel and $1 billion monthly funded volume target. Investors who purchased BETR securities between March 13, 2026 and May 7, 2026 are encouraged to join the class action before the November 20, 2026 lead plaintiff deadline.

Rosen Law Firm is urging FuelCell Energy (FCEL) investors who purchased securities between June 24, 2026 and September 1, 2026 to join a class action lawsuit. The lawsuit alleges that FuelCell made false statements about its business, concealing inadequate manufacturing capacity, slower production rates, higher costs, and likely CEPA-related charges that materially misled investors. The lead plaintiff deadline is November 10, 2026.

The Schwab U.S. Dividend Equity ETF (SCHD) has significantly outperformed the Vanguard High Dividend Yield ETF (VYM) year-to-date, gaining 21.7% versus 10.9%, primarily due to heavy energy sector exposure that has surged 50% this year. However, the author predicts VYM will outperform long-term due to its more balanced sector weightings, lower turnover rate, and focus on quality earnings growth rather than current yield chasing.

A $10,000 investment in an S&P 500 fund over 20 years grew to $82,300, but missing just the 10 best days would have reduced it to $35,700. Most of these best days occurred during market downturns, within two weeks of the worst days, highlighting the danger of market timing and the importance of staying invested.

AbbVie is positioned as a reliable dividend stock that avoids high-yield trap characteristics. With 54 consecutive years of dividend increases, strong free cash flow generation, fixed-rate debt, and blockbuster drugs Skyrizi and Rinvoq generating over $7.5 billion quarterly, AbbVie maintains Dividend King status regardless of interest rate cycles. The company's robust pipeline of 90 clinical programs provides future revenue stability.

Rosen Law Firm has filed a class action lawsuit against Triller Group Inc. (NASDAQ: ILLR) on behalf of investors who purchased securities between October 16, 2024 and December 29, 2025. The lawsuit alleges that Triller made materially false and misleading statements regarding its control of BKFC, financial reporting compliance, NASDAQ listing requirements, and disclosure controls. Investors who wish to serve as lead plaintiff must file by December 14, 2026.

The Rosen Law Firm has announced investigations into potential securities claims against multiple companies including Fervo Energy Company (NASDAQ: FRVO), Triller Group Inc., and Azenta, Inc., alleging that these companies may have issued materially misleading business information to investors. The firm is preparing class action lawsuits seeking recovery of investor losses through contingency fee arrangements.

A shareholder class action lawsuit has been filed against D-Wave Quantum Inc. (NASDAQ: QBTS), alleging that the company made false and misleading statements and overstated its business and financial prospects. Investors who purchased shares between February 26, 2026 and August 25, 2026 and experienced losses are encouraged to contact the law firm. The deadline to be appointed lead plaintiff is December 14, 2026.

VCI Global reported 1H2026 results showing a strategic pivot toward AI infrastructure and token services following divestment of non-core businesses. Total equity increased 19.2% to US$114.70 million while revenue declined 86.37% to US$2.56 million due to portfolio restructuring. The company launched VGAIN Compute platform for AI token access and announced acquisition of controlling stake in Indonesian carbon credit platform PT Fine Carbon Credit Indonesia.

Rosen Law Firm has filed securities class action lawsuits against Millrose Properties, Hims & Hers Health, and Doximity for alleged disclosure failures and misleading statements to investors. Millrose Properties is accused of misrepresenting its business objectives and leasing properties at a loss. Investors have until December 8, 2026 to move the court to serve as lead plaintiff.

Major tech indices declined on October 16, 2026, as AI-focused software stocks experienced a sharp reversal. The S&P 500 fell 1.07%, the Nasdaq Composite plummeted 2.15%, and the Dow Jones slipped 0.34%. Goldman Sachs reported that hedge funds sold AI stocks at the second-fastest pace in over a year, triggering a tactical rotation away from smaller AI names toward larger, steadier companies and defensive stocks.

AbbVie, a Dividend King with 53 consecutive years of dividend increases, would require 723 shares (approximately $206,358) to generate $5,000 in annual dividends at its current price. Despite a modest 2.4% forward yield, the pharmaceutical giant's strong portfolio of blockbuster drugs, low P/E ratio of 16, and 93% stock rally over three years make it an attractive long-term income investment, even compared to higher-yielding alternatives like Pfizer.

Vita Coco Company (COCO) gained 1.77% to close at $58.69 on October 16, 2026, outperforming a declining market. The company is expected to report earnings on October 22 with projected EPS of $0.51 (up 27.50% YoY) and revenue of $232.06 million (up 27.29% YoY). However, COCO carries a Zacks Rank #3 (Hold) rating with a Forward P/E of 29.48, trading at a premium to its industry average of 18.46.

DaVita HealthCare (DVA) closed at $187.25, down 1.01% in the latest session but outperforming the S&P 500's 1.09% decline. The kidney dialysis provider is forecasted to report EPS of $3.78 (up 50.6% YoY) with revenue expected at $3.53 billion (up 3.23% YoY). Trading at a Forward P/E of 12.98 versus the industry average of 20.96, DVA appears undervalued. The stock holds a Zacks Rank #3 (Hold) with a PEG ratio of 0.49, significantly below the industry average of 1.82.

Fiverr International (FVRR) declined 3.61% on October 16, 2026, underperforming the S&P 500's 1.09% loss. The stock has underperformed its sector over the past month. Analysts expect significant earnings declines of 53.25% year-over-year for the upcoming Q3 earnings report on October 29, with full-year earnings projected to fall 39.66%. The company holds a Zacks Rank of #4 (Sell) with consensus EPS estimates revised 5.38% lower in the past month.

Woodward announced the appointment of Paxton McVoy as Executive Vice President and Chief Information Officer, effective October 19, 2026. McVoy, who previously served as Senior Vice President and CIO at Veralto, will lead Woodward's global IT organization and digital strategy, including ERP, data analytics, AI, and cybersecurity initiatives.

EXCLUSIVE: Trump move to restart direct US flights with Lebanon hits roadblock  Reuters

Kuaishou Technology announced the official launch of Kling 4.0, its next-generation video generation model, on October 15, 2026. The upgrade focuses on three priorities: realism, control, and professional quality. Key features include steadier large-scale motion with complex camera work, native generation of up to 30 seconds in a single pass, and Omni Reference supporting up to 15 reference assets and 10 keyframe inputs. The model also supports 10-bit HDR output, 4K/1080p/21:9 ultrawide formats, and video extension up to two minutes. Kling 4.0 has been integrated with Kling MCP and CLI, with API access coming soon for enterprise customers and developers.